When most people think about cancer, they think of bad luck, lifestyle choices, or something that “just happens.” Very few ...

About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...

Researchers used a panel to assess the presence of circulating tumor DNA in plasma samples and detected changes in genes related to the development of adenocarcinoma that indicated both actionability ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Up to 5% of Americans may carry genetic variants associated with cancer risk, according to a cross-sectional analysis.The ...

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...

About 1 in 5 patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called ...

A recent study reveals that bacteria residing within colorectal tumors form distinct ecosystems closely linked to disease ...

The world’s first early-detection blood test for pancreatic cancer is set to be launched in Australia, and is predicted to ...